All Stories

  1. Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes

    Article • International Journal of Gynecological Cancer, February 2024, BMJ

    Dr Shinya Matsuzaki

  2. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer

    Article • October 2023, MDPI AG

    Dr Shinya Matsuzaki

  3. Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian Germ Cell Tumors

    Article • Cancers, September 2023, MDPI AG

    Dr Shinya Matsuzaki

  4. Port‐site hernia: A potentially severe complication of minimally invasive surgery

    Article • Clinical Case Reports, June 2023, Wiley

    Dr Shinya Matsuzaki

  5. Relationship between Abnormal Placenta and Obstetric Outcomes: A Meta-Analysis

    Article • Biomedicines, May 2023, MDPI AG

    Dr Shinya Matsuzaki

  6. Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study

    Article • Cancers, May 2023, MDPI AG

    Dr Shinya Matsuzaki

  7. Vertical compression suture for placenta previa: Using a dedicated needle for uterine compression suture to achieve longitudinal shrinkage of the uterus

    Article • Acta Obstetricia Et Gynecologica Scandinavica, May 2023, Wiley

    Dr Shinya Matsuzaki

  8. Current Evidence on Vasa Previa without Velamentous Cord Insertion or Placental Morphological Anomalies (Type III Vasa Previa): Systematic Review and Meta-Analysis

    Article • Biomedicines, January 2023, MDPI AG

    Dr Shinya Matsuzaki

  9. Surgical Management for Transposed Ovarian Recurrence of Cervical Cancer: A Systematic Review with Our Experience

    Article • September 2022, MDPI AG

    Dr Shinya Matsuzaki

  10. Placenta Accreta Spectrum and Hypertensive Disorders of Pregnancy: Concerns Regarding the Difference in Length of Pregnancy

    Article • Reproductive Sciences, July 2022, Springer Science + Business Media

    Dr Shinya Matsuzaki

  11. Assisted Reproductive Technique and Abnormal Cord Insertion: A Systematic Review and Meta-Analysis

    Article • Biomedicines, July 2022, MDPI AG

    Dr Shinya Matsuzaki

  12. The Effect of Surgeon Volume on the Outcome of Laser Vaporization: A Single-Center Retrospective Study

    Article • May 2022, MDPI AG

    Dr Shinya Matsuzaki

  13. Association between Endometriosis and Delivery Outcomes: A Systematic Review and Meta-Analysis

    Article • Biomedicines, February 2022, MDPI AG

    Dr Shinya Matsuzaki

  14. Placenta Accreta Spectrum Disorder Complicated with Endometriosis: Systematic Review and Meta-Analysis

    Article • Biomedicines, February 2022, MDPI AG

    Dr Shinya Matsuzaki

  15. Conservative management of placenta percreta: is current evidence sufficient?

    Article • American Journal of Obstetrics and Gynecology, January 2022, Elsevier

    Dr Shinya Matsuzaki

  16. Placenta Previa Complicated with Endometriosis: Contemporary Clinical Management, Molecular Mechanisms, and Future Research Opportunities

    Article • Biomedicines, October 2021, MDPI AG

    Dr Shinya Matsuzaki

  17. Minimally Invasive Surgery and Surgical Volume-Specific Survival and Perioperative Outcome: Unmet Need for Evidence in Gynecologic Malignancy

    Article • Journal of Clinical Medicine, October 2021, MDPI AG

    Dr Shinya Matsuzaki

  18. Effects of aspirin and statin use on venous thromboembolism prophylaxis and survival in patients with endometrial cancer

    Article • Expert Opinion on Drug Safety, September 2021, Taylor & Francis

    Dr Shinya Matsuzaki

  19. The association of endometriosis with placenta previa and postpartum hemorrhage: a systematic review and meta-analysis

    Article • American Journal of Obstetrics & Gynecology MFM, September 2021, Elsevier

    Dr Shinya Matsuzaki

  20. A systematic review and meta-analysis of obstetric and maternal outcomes after prior uterine artery embolization

    Article • Scientific Reports, August 2021, Springer Science + Business Media

    Dr Shinya Matsuzaki

  21. CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer

    Article • Cancer Science, July 2021, Wiley

    Dr Shinya Matsuzaki

  22. Unmet need for evidence of volume–outcome relation and maternal outcomes of placenta accreta spectrum

    Article • Acta Obstetricia Et Gynecologica Scandinavica, July 2021, Wiley

    Dr Shinya Matsuzaki

  23. Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study

    Article • European Journal of Surgical Oncology, July 2021, Elsevier

    Dr Shinya Matsuzaki

  24. Clinico‐pathological significance of suspicious peritoneal cytology in endometrial cancer

    Article • Journal of Surgical Oncology, June 2021, Wiley

    Dr Shinya Matsuzaki

  25. Effect of in vitro fertilization–embryo transfer on placenta accreta spectrum according to treatment type

    Article • American Journal of Obstetrics and Gynecology, June 2021, Elsevier

    Dr Shinya Matsuzaki

  26. Stinging abdominal pain at 32 gestational weeks with prior classical uterine incision: Careful assessment or emergency cesarean delivery?

    Article • Clinical Case Reports, May 2021, Wiley

    Dr Shinya Matsuzaki

  27. Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: a systematic review and meta-analysis

    Article • Scientific Reports, April 2021, Springer Science + Business Media

    Dr Shinya Matsuzaki

  28. Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer

    Article • Cancers, April 2021, MDPI AG

    Dr Shinya Matsuzaki

  29. Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer

    Article • Cancers, February 2021, MDPI AG

    Dr Shinya Matsuzaki

  30. Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?

    Article • Archives of Gynecology and Obstetrics, January 2021, Springer Science + Business Media

    Dr Shinya Matsuzaki

  31. Placenta previa with posterior extrauterine adhesion: clinical features and management practice

    Article • BMC Surgery, January 2021, Springer Science + Business Media

    Dr Shinya Matsuzaki

  32. Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer

    Article • Gynecologic Oncology, January 2021, Elsevier

    Dr Shinya Matsuzaki

  33. Proposing the 3‐tier staging system for improving prognostication in Stage I uterine leiomyosarcoma

    Article • Journal of Surgical Oncology, December 2020, Wiley

    Dr Shinya Matsuzaki

  34. Survival effect of intra-operative tumor spillage during minimally invasive hysterectomy for early-stage endometrial cancer: a call for research

    Article • International Journal of Gynecological Cancer, December 2020, BMJ

    Dr Shinya Matsuzaki

  35. In-vitro fertilisation–embryo-transfer complicates the antenatal diagnosis of placenta accreta spectrum using MRI: a retrospective analysis

    Article • Clinical Radiology, December 2020, Elsevier

    Dr Shinya Matsuzaki

  36. Reply

    Article • American Journal of Obstetrics and Gynecology, December 2020, Elsevier

    Dr Shinya Matsuzaki

  37. Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection

    Article • PLoS ONE, November 2020, PLOS

    Dr Shinya Matsuzaki

  38. National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA

    Article • Acta Obstetricia Et Gynecologica Scandinavica, November 2020, Wiley

    Dr Shinya Matsuzaki

  39. Conservative management for adherent placenta after live birth in angular or interstitial pregnancies: A new entity “angular placenta attachment”

    Article • Taiwanese Journal of Obstetrics and Gynecology, November 2020, Elsevier

    Dr Shinya Matsuzaki

  40. Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic

    Article • European Journal of Cancer, November 2020, Elsevier

    Dr Shinya Matsuzaki

  41. Malignant peritoneal cytology in endometrial cancer: Areas of unmet need for evidence

    Article • European Journal of Cancer, November 2020, Elsevier

    Dr Shinya Matsuzaki

  42. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States

    Article • American Journal of Obstetrics and Gynecology, November 2020, Elsevier

    Dr Shinya Matsuzaki

  43. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity

    Article • Gynecologic Oncology, November 2020, Elsevier

    Dr Shinya Matsuzaki

  44. Semi-quantification of grade 2 endometrioid endometrial cancer: A rationale of inter-observer agreement per pathologists

    Article • Gynecologic Oncology, November 2020, Elsevier

    Dr Shinya Matsuzaki

  45. Side-to-end reanastomosis after lower anterior resection (STELAR) in Gynecologic Cancer Surgery

    Article • Gynecologic Oncology, November 2020, Elsevier

    Dr Shinya Matsuzaki

  46. Unified interpretation of scalegenesis in conformally extended standard models: a dynamical origin of Higgs portal *

    Article • Chinese Physics C, November 2020, Institute of Physics Publishing

    Dr Shinya Matsuzaki

  47. ASO Author Reflections: Spotlight on Malignant Peritoneal Cytology in Uterine Sarcoma: A Potential Avenue for Future Research

    Article • Annals of Surgical Oncology, October 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  48. Management of recurrent granulosa cell tumor of the ovary: Contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option

    Article • Journal of Obstetrics and Gynaecology Research, October 2020, Wiley

    Dr Shinya Matsuzaki

  49. Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma

    Article • Annals of Surgical Oncology, October 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  50. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer

    Article • Gynecologic Oncology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  51. Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology

    Article • American Journal of Obstetrics and Gynecology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  52. Diagnosis shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study

    Article • Gynecologic Oncology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  53. Differences in effectiveness of concurrent metformin with local versus systemic progestin therapy for obese women with complex atypical hyperplasia

    Article • Gynecologic Oncology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  54. Dynamic scale anomalous transport in QCD with electromagnetic background

    Article • Journal of High Energy Physics, October 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  55. Evolving population-based statistics for rare epithelial ovarian cancers

    Article • Gynecologic Oncology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  56. Incidence and characteristics of subsequent breast cancer after uterine cancer: A population-based analysis

    Article • Gynecologic Oncology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  57. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer

    Article • Geburtshilfe und Frauenheilkunde, October 2020, Thieme Publishing Group

    Dr Shinya Matsuzaki

  58. Minimally invasive surgery for early-stage ovarian cancer: Association between surgical volume and perioperative outcomes

    Article • Gynecologic Oncology, October 2020, Elsevier

    Dr Shinya Matsuzaki

  59. EFFECT OF HOSPITAL VOLUME ON THE INCIDENCE OF MAJOR COMPLICATIONS IN PATIENTS HOSPITALIZED WITH OVARIAN HYPERSTIMULATION SYNDROME

    Article • Fertility and Sterility, September 2020, Elsevier

    Dr Shinya Matsuzaki

  60. IMPACT OF BODY HABITUS ON INCIDENCE OF COMPLICATIONS IN PATIENTS HOSPITALIZED WITH OVARIAN HYPERSTIMULATION SYNDROME

    Article • Fertility and Sterility, September 2020, Elsevier

    Dr Shinya Matsuzaki

  61. Nonlinear Optics with Near-Infrared Excitation Enable Real-Time Quantitative Diagnosis of Human Cervical Cancers

    Article • Cancer Research, September 2020, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  62. Financial viewpoint of minimally invasive radical hysterectomy for early cervical cancer: another disadvantage?

    Article • International Journal of Gynecological Cancer, August 2020, BMJ

    Dr Shinya Matsuzaki

  63. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma

    Article • American Journal of Obstetrics and Gynecology, August 2020, Elsevier

    Dr Shinya Matsuzaki

  64. Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period

    Article • Gynecologic Oncology, August 2020, Elsevier

    Dr Shinya Matsuzaki

  65. Sonographic findings after induced medical abortion at 12–21 weeks of gestation: Retrospective cohort study

    Article • Contraception, August 2020, Elsevier

    Dr Shinya Matsuzaki

  66. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer

    Article • European Journal of Cancer, July 2020, Elsevier

    Dr Shinya Matsuzaki

  67. Minimally Invasive Surgery and Risk of Capsule Rupture for Women With Early-Stage Ovarian Cancer

    Article • JAMA Oncology, July 2020, American Medical Association (AMA)

    Dr Shinya Matsuzaki

  68. Minimally invasive surgery for early-stage ovarian cancer: Association between hospital surgical volume and short-term perioperative outcomes

    Article • Gynecologic Oncology, July 2020, Elsevier

    Dr Shinya Matsuzaki

  69. Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy

    Article • American Journal of Obstetrics and Gynecology, July 2020, Elsevier

    Dr Shinya Matsuzaki

  70. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic

    Article • Gynecologic Oncology, July 2020, Elsevier

    Dr Shinya Matsuzaki

  71. Fertility‐sparing treatment for early‐stage epithelial ovarian cancer: Contemporary oncologic, reproductive and endocrinologic perspectives

    Article • Journal of Obstetrics and Gynaecology Research, June 2020, Wiley

    Dr Shinya Matsuzaki

  72. Utility of the 3-tier grouping system for survival discriminatory ability in stage IIA cervical cancer

    Article • European Journal of Surgical Oncology, June 2020, Elsevier

    Dr Shinya Matsuzaki

  73. Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary Review

    Article • Cancers, May 2020, MDPI AG

    Dr Shinya Matsuzaki

  74. Proposal of a Two-Tier System in Grouping Adenocarcinoma of the Uterine Cervix

    Article • Cancers, May 2020, MDPI AG

    Dr Shinya Matsuzaki

  75. Route-specific association of progestin therapy and concurrent metformin use in obese women with complex atypical hyperplasia

    Article • International Journal of Gynecological Cancer, May 2020, BMJ

    Dr Shinya Matsuzaki

  76. Cesarean radical hysterectomy for cervical cancer in the United States: a national study of surgical outcomes

    Article • American Journal of Obstetrics and Gynecology, May 2020, Elsevier

    Dr Shinya Matsuzaki

  77. Populational trends and outcomes of postoperative radiotherapy for high-risk early-stage cervical cancer with lymph node metastasis: concurrent chemo-radiotherapy versus radiotherapy alone

    Article • American Journal of Obstetrics and Gynecology, May 2020, Elsevier

    Dr Shinya Matsuzaki

  78. Inverse mass hierarchy of light scalar mesons driven by anomaly-induced flavor breaking

    Article • Progress of Theoretical and Experimental Physics, May 2020, Oxford University Press (OUP)

    Dr Shinya Matsuzaki

  79. Significance of lymph node ratio on survival of women with borderline ovarian tumors

    Article • Archives of Gynecology and Obstetrics, April 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  80. Delayed hysterectomy versus continuing conservative management for placenta percreta: Which is better?

    Article • American Journal of Obstetrics and Gynecology, April 2020, Elsevier

    Dr Shinya Matsuzaki

  81. Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States

    Article • Gynecologic Oncology, April 2020, Elsevier

    Dr Shinya Matsuzaki

  82. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study

    Article • Gynecologic Oncology, April 2020, Elsevier

    Dr Shinya Matsuzaki

  83. Evolving population-based statistics for rare epithelial ovarian cancers

    Article • Gynecologic Oncology, April 2020, Elsevier

    Dr Shinya Matsuzaki

  84. Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study

    Article • Archives of Gynecology and Obstetrics, March 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  85. Conservative surgery for ovarian torsion in young women: perioperative complications and national trends

    Article • BJOG An International Journal of Obstetrics & Gynaecology, March 2020, Wiley

    Dr Shinya Matsuzaki

  86. Obstetric Outcomes of Pregnancy After Uterine Artery Embolization

    Article • International Journal of Women s Health, March 2020, Taylor & Francis

    Dr Shinya Matsuzaki

  87. Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence

    Article • Current Oncology Reports, February 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  88. PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer

    Article • International Immunology, February 2020, Oxford University Press (OUP)

    Dr Shinya Matsuzaki

  89. Chiral-imbalance density wave in baryonic matters

    Article • Journal of Physics G Nuclear and Particle Physics, February 2020, Institute of Physics Publishing

    Dr Shinya Matsuzaki

  90. Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States

    Article • Archives of Gynecology and Obstetrics, January 2020, Springer Science + Business Media

    Dr Shinya Matsuzaki

  91. Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine

    Article • Human Vaccines & Immunotherapeutics, January 2020, Taylor & Francis

    Dr Shinya Matsuzaki

  92. Implementation of Multidisciplinary Practice Change to Improve Outcomes for Women with Placenta Accreta Spectrum

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, January 2020, Elsevier

    Dr Shinya Matsuzaki

  93. Efficacy of Prophylactic Antibiotics in Bakri Intrauterine Balloon Placement: A Single-Center Retrospective Analysis and Literature Review

    Article • American Journal of Perinatology Reports, January 2020, Thieme Publishing Group

    Dr Shinya Matsuzaki

  94. Persistent funic presentation due to velamentous cord insertion adjacent to the internal os but not vasa previa

    Article • Taiwanese Journal of Obstetrics and Gynecology, January 2020, Elsevier

    Dr Shinya Matsuzaki

  95. 527: Implementation of multidisciplinary policy to improve outcomes for women with morbidly adherent placental disease

    Article • American Journal of Obstetrics and Gynecology, January 2020, Elsevier

    Dr Shinya Matsuzaki

  96. Horizontal Cervix as a Novel Sign for Predicting Adhesions on the Posterior Extrauterine Wall in Cases of Placenta Previa

    Article • Journal of Clinical Medicine, December 2019, MDPI AG

    Dr Shinya Matsuzaki

  97. Systematic review on the needle and suture types for uterine compression sutures: a literature review

    Article • BMC Surgery, December 2019, Springer Science + Business Media

    Dr Shinya Matsuzaki

  98. Emerging serine-threonine kinase inhibitors for treating ovarian cancer

    Article • Expert Opinion on Emerging Drugs, November 2019, Taylor & Francis

    Dr Shinya Matsuzaki

  99. Endometrial carcinoma in a gravid uterus: a case report and literature review

    Article • BMC Pregnancy and Childbirth, November 2019, Springer Science + Business Media

    Dr Shinya Matsuzaki

  100. Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies

    Article • Journal of Surgical Oncology, November 2019, Wiley

    Dr Shinya Matsuzaki

  101. Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study

    Article • Journal of Clinical Medicine, November 2019, MDPI AG

    Dr Shinya Matsuzaki

  102. Vesicoureteral Injury during Benign Hysterectomy: Minimally Invasive Laparoscopic Surgery versus Laparotomy

    Article • Journal of Minimally Invasive Gynecology, November 2019, Elsevier

    Dr Shinya Matsuzaki

  103. Temporal trends and characteristics of suicide among women with gynecologic malignancy in the United States

    Article • Gynecologic Oncology Reports, November 2019, Elsevier

    Dr Shinya Matsuzaki

  104. EP1084 The change of opinions on HPV vaccination in Japan: a 5-year follow-up survey of obstetricians and gynecologists regarding their opinions about the HPV vaccine

    Article • November 2019, BMJ

    Dr Shinya Matsuzaki

  105. A rare type of vasa previa

    Article • Clinical Case Reports, September 2019, Wiley

    Dr Shinya Matsuzaki

  106. Treatment and outcome of placenta percreta: primary cesarean hysterectomy versus conservative management

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, September 2019, Elsevier

    Dr Shinya Matsuzaki

  107. Histologic correlation between smartphone and coloposcopic findings in patients with abnormal cervical cytology: experiences in a tertiary referral hospital

    Article • American Journal of Obstetrics and Gynecology, September 2019, Elsevier

    Dr Shinya Matsuzaki

  108. Letter to “Cervical varices unrelated to placenta previa as an unusual cause of antepartum hemorrhage: A case report and literature review”: Successful management of postpartum hemorrhage due to cervical varix: Modified Matsubara Nelaton method using B...

    Article • Taiwanese Journal of Obstetrics and Gynecology, September 2019, Elsevier

    Dr Shinya Matsuzaki

  109. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors

    Article • International Journal of Molecular Sciences, August 2019, MDPI AG

    Dr Shinya Matsuzaki

  110. Copper ions are novel therapeutic agents for uterine leiomyosarcoma

    Article • American Journal of Obstetrics and Gynecology, July 2019, Elsevier

    Dr Shinya Matsuzaki

  111. Abstract 3853: CD70 antibody-drug conjugate: A novel therapeutic agent for platinum-resistant ovarian carcinoma

    Article • Cancer Research, July 2019, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  112. Abstract 33:Ex vivodrug sensitivity assay with a panel of cancer patient-derived spheroids of small cell neuroendocrine carcinoma of uterine cervix

    Article • July 2019, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  113. Abstract 3029: Targeting Annexin A4 with antisense oligonucleotides improves platinum resistance of ovarian cancer

    Article • July 2019, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  114. Enhanced di-Higgs signal from hidden scalar QCD at leading-order in the scale-symmetry limit

    Article • April 2019, American Physical Society (APS)

    Dr Shinya Matsuzaki

  115. Trends in incidence and long-term survival of Japanese women with vulvar cancer: a population-based analysis

    Article • International Journal of Clinical Oncology, April 2019, Springer Science + Business Media

    Dr Shinya Matsuzaki

  116. New dedicated blunt straight needles and sutures for uterine compression sutures: a retrospective study and literature review

    Article • BMC Surgery, March 2019, Springer Science + Business Media

    Dr Shinya Matsuzaki

  117. When is the ideal time to remove cerclage in cases requiring cesarean hysterectomy for placenta accreta spectrum?

    Article • International Journal of Reproduction Contraception Obstetrics and Gynecology, March 2019, Medip Academy

    Dr Shinya Matsuzaki

  118. Relation between the number of board‐certified gynecologic oncologists per hospital and survival of cervical cancer

    Article • Journal of Obstetrics and Gynaecology Research, March 2019, Wiley

    Dr Shinya Matsuzaki

  119. HPV vaccination in Japan: what is happening in Japan?

    Article • Expert Review of Vaccines, February 2019, Taylor & Francis

    Takayuki Enomoto, Dr Shinya Matsuzaki

  120. Single versus multiple cervical dilation by osmotic dilator before induction of labor for second‐trimester abortion

    Article • Journal of Obstetrics and Gynaecology Research, February 2019, Wiley

    Dr Shinya Matsuzaki

  121. Cover Image

    Article • Clinical Case Reports, February 2019, Wiley

    Dr Shinya Matsuzaki

  122. Vasa Previa

    Article • New England Journal of Medicine, January 2019, New England Journal of Medicine (NEJM/MMS)

    Dr Shinya Matsuzaki

  123. Epidemiologic and Clinical Analysis of Cervical Cancer Using Data from the Population-Based Osaka Cancer Registry

    Article • Cancer Research, January 2019, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  124. Laparoscopic Radical Hysterectomy

    Article • January 2019, Springer Science + Business Media

    Dr Shinya Matsuzaki

  125. Gross image of vasa previa restored in the postpartum period

    Article • Clinical Case Reports, December 2018, Wiley

    Dr Shinya Matsuzaki

  126. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer

    Article • Journal of Obstetrics and Gynaecology Research, November 2018, Wiley

    Dr Shinya Matsuzaki

  127. Small Cell Carcinomas of the Uterine Cervix and Lung: Proteomics Reveals Similar Protein Expression Profiles

    Article • International Journal of Gynecological Cancer, November 2018, BMJ

    Dr Shinya Matsuzaki

  128. Magnetic field effect on nuclear matter from a Skyrmion crystal model

    Article • September 2018, American Physical Society (APS)

    Dr Shinya Matsuzaki

  129. An evident asymmetrical uterus during cesarean delivery

    Article • Clinical Case Reports, September 2018, Wiley

    Dr Shinya Matsuzaki

  130. A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

    Article • Cancer Chemotherapy and Pharmacology, July 2018, Springer Science + Business Media

    Dr Shinya Matsuzaki

  131. Abstract 1434: LSR promotes lipid metabolism via beta oxidation and contributes cell viability in epithelial ovarian cancer

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  132. Obstetric outcomes and acceptance of alternative therapies to blood transfusion by Jehovah’s Witnesses in Japan: a single-center study

    Article • International Journal of Hematology, June 2018, Springer Science + Business Media

    Dr Shinya Matsuzaki

  133. Intratumoral Delivery of an Adenoviral Vector Carrying theSOCS-1Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1

    Article • Molecular Cancer Therapeutics, June 2018, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  134. Obstetric outcome in patients with a unicornuate uterus after laparoscopic resection of a rudimentary horn

    Article • Journal of Obstetrics and Gynaecology Research, March 2018, Wiley

    Dr Shinya Matsuzaki

  135. Conservative management of placenta percreta

    Article • International Journal of Gynecology & Obstetrics, January 2018, Wiley

    Dr Shinya Matsuzaki

  136. Motivating Mothers to Recommend Their 20-Year-Old Daughters Receive Cervical Cancer Screening: A Randomized Study

    Article • Journal of Epidemiology, January 2018, Japan Epidemiological Association

    Dr Shinya Matsuzaki

  137. One-family walking technicolor in light of LHC Run II

    Article • International Journal of Modern Physics A, December 2017, World Scientific Pub Co Pte Lt

    Dr Shinya Matsuzaki

  138. Successful anticoagulant therapy for disseminated intravascular coagulation during conservative management of placenta percreta: a case report and literature review

    Article • BMC Pregnancy and Childbirth, December 2017, Springer Science + Business Media

    Dr Shinya Matsuzaki

  139. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

    Article • Cancer Research, November 2017, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  140. Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer

    Article • International Journal of Cancer, October 2017, Wiley

    Dr Shinya Matsuzaki

  141. HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine

    Article • International Journal of Clinical Oncology, October 2017, Springer Science + Business Media

    Dr Shinya Matsuzaki

  142. LSR PROMOTES LIPID UPTAKE, BETA-OXIDATION AND SUBSEQUENT TUMOR GROWTH IN OVARIAN CANCER

    Article • October 2017, Morressier

    Dr Shinya Matsuzaki

  143. Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry

    Article • Medicine, August 2017, Wolters Kluwer Health

    Dr Shinya Matsuzaki

  144. Investigation of perioperative complications associated with use of uterine compression sutures

    Article • International Journal of Gynecology & Obstetrics, July 2017, Wiley

    Dr Shinya Matsuzaki

  145. Abstract 1397: Antisense oligo nucleotide of Annexin A4 improved platinum resistance in ovarian clear cell cancer

    Article • Cancer Research, July 2017, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  146. Abstract 1200: Novel strategy to overcome platinum resistance in uterine leiomyosarcoma; blocking ATP7B by copper ion

    Article • Cancer Research, July 2017, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  147. A case of acute Sheehan’s syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage

    Article • BMC Pregnancy and Childbirth, June 2017, Springer Science + Business Media

    Dr Shinya Matsuzaki

  148. Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases

    Article • International Journal of Clinical Oncology, April 2017, Springer Science + Business Media

    Dr Shinya Matsuzaki

  149. Pregnancy outcomes in women with different doses of corticosteroid supplementation during labor and delivery

    Article • Journal of Obstetrics and Gynaecology Research, April 2017, Wiley

    Dr Shinya Matsuzaki

  150. Lifetime of rho meson in correlation with magnetic-dimensional reduction

    Article • The European Physical Journal A, April 2017, Springer Science + Business Media

    Dr Shinya Matsuzaki

  151. ‘Smartscopy’ as an alternative device for cervical cancer screening: a pilot study

    Article • BMJ Innovations, March 2017, BMJ

    Dr Shinya Matsuzaki

  152. Realistic fear of cervical cancer risk in Japan depending on birth year

    Article • Human Vaccines & Immunotherapeutics, March 2017, Taylor & Francis

    Dr Shinya Matsuzaki

  153. Vasa previa with an intact amniotic membrane

    Article • American Journal of Obstetrics and Gynecology, March 2017, Elsevier

    Dr Shinya Matsuzaki

  154. Treatment and repair of uterine scar dehiscence during cesarean section

    Article • Clinical Case Reports, January 2017, Wiley

    Dr Shinya Matsuzaki

  155. A case report of a successful pregnancy in a woman diagnosed with common variable immunodeficiency with impaired B cell class-switching and the decrease in naïve CD4 positive T cell

    Article • Journal of Reproductive Immunology, November 2016, Elsevier

    Dr Shinya Matsuzaki

  156. Placenta accreta following laparoscopic adenomyomectomy: a case report

    Article • Clinical and Experimental Obstetrics & Gynecology, October 2016, IMR Press

    Dr Shinya Matsuzaki

  157. Project conducted in Hirakata to improve cervical cancer screening rates in 20-year-old Japanese: Influencing parents to recommend that their daughters undergo cervical cancer screening

    Article • Journal of Obstetrics and Gynaecology Research, September 2016, Wiley

    Dr Shinya Matsuzaki

  158. Successful conservative management of placenta percreta: Investigation by serial magnetic resonance imaging of the clinical course and a literature review

    Article • Journal of Obstetrics and Gynaecology Research, August 2016, Wiley

    Dr Shinya Matsuzaki

  159. Response to ‘Letter to “Cervical varix complicated by placenta previa: A case report and literature review”: A novel simple abdominal traction stitch (Matsubara) to hold the Bakri balloon’

    Article • Journal of Obstetrics and Gynaecology Research, August 2016, Wiley

    Dr Shinya Matsuzaki

  160. Abstract 4998: Lipolysis-stimulated lipoprotein receptor (LSR) can be a novel therapeutic target of ovarian cancer

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  161. Short interpregnancy interval after B-Lynch uterine compression suture: a case report

    Article • Clinical and Experimental Obstetrics & Gynecology, June 2016, IMR Press

    Dr Shinya Matsuzaki

  162. Chemotherapy for Uterine Sarcomas: A Review

    Article • May 2016, Bentham Science Publishers

    Dr Shinya Matsuzaki

  163. Placenta accreta following hysteroscopic myomectomy

    Article • Clinical Case Reports, April 2016, Wiley

    Dr Shinya Matsuzaki

  164. Cesarean delivery via a transverse uterine fundal incision for the successful management of a low-lying placenta and aplastic anemia

    Article • Clinical and Experimental Obstetrics & Gynecology, April 2016, IMR Press

    Dr Shinya Matsuzaki

  165. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

    Article • Annals of Oncology, April 2016, Oxford University Press (OUP)

    Dr Shinya Matsuzaki

  166. Cervical varix complicated by placenta previa: A case report and literature review

    Article • Journal of Obstetrics and Gynaecology Research, February 2016, Wiley

    Dr Shinya Matsuzaki

  167. Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas

    Article • British Journal of Cancer, February 2016, Springer Science + Business Media

    Dr Shinya Matsuzaki

  168. Long-term survival in small-cell carcinoma of the endometrium with liver and brain metastases

    Article • Anti-Cancer Drugs, February 2016, Wolters Kluwer Health

    Dr Shinya Matsuzaki

  169. Utility of an Internal Retractor (EndoGrab) for the Management of the Vesicouterine Ligament during Laparoscopic Radical Hysterectomy

    Article • Gynecologic and Obstetric Investigation, January 2016, Karger Publishers

    Dr Shinya Matsuzaki

  170. Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution

    Article • International Journal of Clinical Oncology, December 2015, Springer Science + Business Media

    Dr Shinya Matsuzaki

  171. Early metabolic change in 18F-FDG-PET by measuring the single largest lesion predicts chemotherapeutic effects and patients’ survival: PEACH study

    Article • Cancer Chemotherapy and Pharmacology, December 2015, Springer Science + Business Media

    Dr Shinya Matsuzaki

  172. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives

    Article • Cancer Cell International, December 2015, Springer Science + Business Media

    Dr Shinya Matsuzaki

  173. A Case of Extragonadal Teratoma in the Pouch of Douglas and Literature Review

    Article • Journal of Minimally Invasive Gynecology, November 2015, Elsevier

    Dr Shinya Matsuzaki

  174. CpG oligodeoxynucleotides potentiate the antitumor activity of anti‐ BST 2 antibody

    Article • Cancer Science, October 2015, Wiley

    Dr Shinya Matsuzaki

  175. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan

    Article • International Journal of Clinical Oncology, July 2015, Springer Science + Business Media

    Dr Shinya Matsuzaki

  176. A novel device for cleaning the camera port during laparoscopic surgery

    Article • Surgical Endoscopy, June 2015, Springer Science + Business Media

    Dr Shinya Matsuzaki

  177. Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013

    Article • International Journal of Clinical Oncology, May 2015, Springer Science + Business Media

    Dr Shinya Matsuzaki

  178. Managing cesarean section in a patient with rotated uterus due to a large myoma

    Article • Clinical Case Reports, March 2015, Wiley

    Dr Shinya Matsuzaki

  179. Optimal Timing for Drainage of Infected Lymphocysts After Lymphadenectomy for Gynecologic Cancer

    Article • International Journal of Gynecological Cancer, February 2015, Wolters Kluwer Health

    Dr Shinya Matsuzaki

  180. A Case Report and Literature Review of Midtrimester Termination of Pregnancy Complicated by Placenta Previa and Placenta Accreta

    Article • American Journal of Perinatology Reports, December 2014, Thieme Publishing Group

    Dr Shinya Matsuzaki

  181. Pregnancy management for a patient with graft occlusion after right iliac artery bypass surgery

    Article • Journal of Obstetrics and Gynaecology Research, December 2014, Wiley

    Dr Shinya Matsuzaki

  182. Clear cell adenocarcinoma of the peritoneum: a case report and literature review

    Article • Journal of Ovarian Research, October 2014, Springer Science + Business Media

    Dr Shinya Matsuzaki

  183. Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner

    Article • Oncotarget, September 2014, Impact Journals, LLC

    Dr Shinya Matsuzaki

  184. Placenta percreta managed by transverse uterine fundal incision with retrograde cesarean hysterectomy: a novel surgical approach

    Article • Clinical Case Reports, September 2014, Wiley

    Dr Shinya Matsuzaki

  185. Large Uterine Cervical Adenomyoma Excised by Vaginal Approach: Case Report, Images, and Literature Review

    Article • Journal of Minimally Invasive Gynecology, September 2014, Elsevier

    Dr Shinya Matsuzaki

  186. Interstitial Pregnancy Resulting in a Viable Infant Coexistent with Massive Perivillous Fibrin Deposition: A Case Report and Literature Review

    Article • American Journal of Perinatology Reports, March 2014, Thieme Publishing Group

    Dr Shinya Matsuzaki

  187. Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers

    Article • Expert Opinion on Therapeutic Targets, January 2014, Informa Healthcare

    Dr Shinya Matsuzaki

  188. Placenta percreta with a vaginal fistula after successful management by uterine transverse fundal incision and subsequent cesarean hysterectomy

    Article • Obstetrics & Gynecology Science, January 2014, Korean Society of Obstetrics and Gynecology (KAMJE)

    Dr Shinya Matsuzaki

  189. Challenges in Diagnosis of Pseudo Vasa Previa

    Article • Case Reports in Obstetrics and Gynecology, January 2014, Hindawi Publishing Corporation

    Dr Shinya Matsuzaki

  190. Successful management of placenta percreta by cesarean hysterectomy with transverse uterine fundal incision

    Article • International Journal of Reproduction Contraception Obstetrics and Gynecology, January 2014, Medip Academy

    Dr Shinya Matsuzaki

  191. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A

    Article • International Journal of Cancer, October 2013, Wiley

    Dr Shinya Matsuzaki

  192. Endometrial Thickness Measured by Ultrasonography in Postmenopausal Patients With Endometrial Carcinoma Has Significance, Irrespective of Histological Subtype

    Article • International Journal of Gynecological Cancer, September 2013, Wolters Kluwer Health

    Dr Shinya Matsuzaki

  193. Abstract 4059: Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  194. Abstract 4057: Functional domain of Annexin A4: which domain is indispensable for chemoresistance to platinum drugs.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  195. Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin

    Article • Cancer Chemotherapy and Pharmacology, March 2013, Springer Science + Business Media

    Dr Shinya Matsuzaki

  196. Disease flare-ups and obstetric outcomes in pregnant women with systemic lupus erythematosus

    Article • Hypertension Research in Pregnancy, January 2013, Japan Society for the Study of Hypertension in Pregnancy

    Dr Shinya Matsuzaki

  197. Vulvovaginal aggressive angiomyxoma mimicking lymphedema complicated with Behcet’s disease: a case report and review of the literature

    Article • International Cancer Conference Journal, November 2012, Springer Science + Business Media

    Dr Shinya Matsuzaki

  198. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis

    Article • Inflammatory Bowel Diseases, November 2012, Wolters Kluwer Health

    Dr Shinya Matsuzaki

  199. Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer

    Article • Cancer Epidemiology Biomarkers & Prevention, September 2012, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  200. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer

    Article • International Journal of Cancer, July 2012, Wiley

    Dr Shinya Matsuzaki

  201. Abstract 4225: Annexin A4 induces chemoresistance for multiple drugs in ovarian clear cell carcinoma

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  202. Prediction, based on resection margins, of long-term outcome of cervical intraepithelial neoplasia 3 treated by Shimodaira-Taniguchi conization

    Article • Archives of Gynecology and Obstetrics, November 2011, Springer Science + Business Media

    Dr Shinya Matsuzaki

  203. Intraoperative Frozen Section Assessment of Myometrial Invasion and Histology of Endometrial Cancer Using the Revised FIGO Staging System

    Article • International Journal of Gynecological Cancer, July 2011, Wolters Kluwer Health

    Dr Shinya Matsuzaki

  204. Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later

    Article • American Journal of Obstetrics and Gynecology, June 2011, Elsevier

    Dr Shinya Matsuzaki

  205. Abstract 5108: Quantitative proteomic analysis of cell-surface membrane proteins: Biomarker discovery in endometrial cancer

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Dr Shinya Matsuzaki

  206. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications

    Article • Cancer Science, February 2011, Wiley

    Dr Shinya Matsuzaki

  207. CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma

    Article • Journal of Cancer Research and Clinical Oncology, June 2010, Springer Science + Business Media

    Dr Shinya Matsuzaki

  208. Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin

    Article • Cancer Chemotherapy and Pharmacology, June 2010, Springer Science + Business Media

    Dr Shinya Matsuzaki

  209. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up

    Article • International Journal of Clinical Oncology, April 2010, Springer Science + Business Media

    Dr Shinya Matsuzaki

  210. A Case of Disseminated Peritoneal Leiomyomatosis Developing after Laparoscope-Assisted Myomectomy

    Article • Gynecologic and Obstetric Investigation, January 2009, Karger Publishers

    Dr Shinya Matsuzaki

  211. Cesarean delivery after successful external cephalic version of breech presentation at term

    Article • International Journal of Gynecology & Obstetrics, May 2006, Wiley

    Dr Shinya Matsuzaki